ARTELO BIOSCIENCES INC
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
ARTL$2.14+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2023 and 2022
Consolidated Balance Sheets
(In thousands, except share data)
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $2,815 | $6,888 |
| Trading marketable securities | 7,611 | 9,150 |
| Available-for-sale securities (amortized cost of $0 and $1,502, respectively) | - | 1,495 |
| Prepaid expenses and other current assets | 554 | 789 |
| Total Current Assets | 10,980 | 18,322 |
| Operating lease right-of-use assets | 21 | 60 |
| Intangible asset | 2,039 | 2,039 |
| Other assets | 3 | 3 |
| TOTAL ASSETS | $13,043 | $20,424 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $1,238 | $905 |
| Due to related parties | 30 | 53 |
| Operating lease liabilities - current portion | 23 | 40 |
| Total Current Liabilities | 1,291 | 998 |
| Operating lease liabilities | - | 23 |
| TOTAL LIABILITIES | 1,291 | 1,021 |
| STOCKHOLDERS' EQUITY | ||
| Preferred Stock, par value $0.001, 416,667 shares authorized, | ||
| 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022 | - | - |
| Common Stock, par value $0.001, 50,000,000 shares authorized, as of December 31, 2023 and December 31, 2022, 3,188,959 and 2,855,688 shares issued and outstanding as of December 31, 2023 and December 31, 2022 | 3 | 3 |
| Additional paid-in capital | 52,262 | 50,675 |
| Accumulated deficit | (40,310) | (31,021) |
| Accumulated other comprehensive loss | (203) | (254) |
| TOTAL STOCKHOLDERS' EQUITY | 11,752 | 19,403 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $13,043 | $20,424 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.